Akili, Inc. (NasdaqCM: AKLI)
Health Care · Health Care Technology · US
$—
— today · — 1Y
Akili, Inc. (NasdaqCM: AKLI) operates in the Health Care Technology industry within the Health Care sector.
Tweenvest scores Akili, Inc. across four factors: quality 27/100. Its strongest factor is quality.
AKLI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $1.95M
- P/E
- —
- EPS
- -0.62
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 68
- Next earnings
- —
About Akili, Inc.
Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitive functioning. This company operates from its headquarters in Boston, Massachusetts.
- ISIN
- US00974B1070
- Founded
- 2011
- Listed since
- Jun 30, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.36B | $243.90 | -1.84% |
| Pro Medicus LimitedASX: PME | $14.46B | AU$193.43 | +0.96% |
| M3, Inc.TSE: 2413 | $7.21B | ¥1,719.50 | +0.67% |
| Sectra AB (publ)OM: SECT B | $5.60B | Skr275.80 | -0.79% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.86B | $25.19 | -0.63% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $24.79 | -2.02% |
| HeartFlow, Inc.NasdaqGS: HTFL | $4.37B | $50.55 | +0.70% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.